Stocks and Investing
Stocks and Investing
Thu, May 5, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, May 4, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, May 3, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, May 2, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joseph Schwartz Downgraded (SRPT) to Sell and Decreased Target to $5 on, May 2nd, 2016
Joseph Schwartz of Leerink Swann, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Sell and Decreased Target from $13 to $5 on, May 2nd, 2016.
Joseph has made no other calls on SRPT in the last 4 months.
There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yun Zhong of "Janney Montgomery Scott" Initiated at Hold on, Wednesday, April 20th, 2016
- Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $15 on, Tuesday, January 19th, 2016
This is the rating of the analyst that currently disagrees with Joseph
- Mike Guo of "SunTrust Robinson Humphrey" Downgraded from Hold to Sell and Decreased Target to $4 on, Tuesday, April 26th, 2016
Contributing Sources